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In lean individuals, acute aerobic exercise is reported to transiently suppress sensations of appetite, suppress blood concentrations
of acylated ghrelin (AG), and increase glucagon-like peptide-1 (GLP-1) and peptide-YY (PYY). Findings in overweight/obese
individuals have yet to be synthesised. In this systematic review and meta-analysis, we quantified the effects that acute exercise has
on AG and total PYY and GLP-1 in overweight/obese individuals. The potential for body mass index (BMI) to act as a moderator
for AG was also explored. Six published studies (73 participants, 78% male, mean BMI: 30.6 kg⋅m−2) met the inclusion criteria.
Standardised mean differences (SMDs) and standard errors were extracted for AG and total PYY and GLP-1 concentrations in
control and exercise trials and synthesised using a random effects meta-analysis model. BMI was the predictor in metaregression
for AG. Exercisemoderately suppressedAG area-under-the-curve concentrations (pooled SMD:−0.34, 95%CI:−0.53 to−0.15).The
magnitude of this reduction was greater for higher mean BMIs (pooled metaregression slope: −0.04 SMD/kg⋅m−2 (95% CI: −0.07
to 0.00)). Trivial SMDs were obtained for total PYY (0.10, 95% CI: −0.13 to 0.31) and GLP-1 (−0.03, 95% CI: −0.18 to 0.13). This
indicates that exercise in overweight/obese individuals moderately alters AG in a direction that could be associated with decreased
hunger and energy intake. This trial is registered with PROSPERO: CRD42014006265.
1. Introduction
Adults with a body mass index (BMI) of equal to or greater
than 25 kg⋅m−2 are classified as overweight, whilst those with
a BMI equal to or greater than 30 kg⋅m−2 are classified as
obese [1]. In 2008, it was estimated that 1.4 billion adults were
overweight worldwide. Of these, 200 million men and nearly
300 million women were obese [1]. Obesity is associated with
an increased risk of type 2 diabetes, coronary heart disease,
and some types of cancer, as well as strokes [2]. The health
risks and financial burden associated with overweight and
obesity are causes for concern. Governments are developing
schemes and guidelines to help counter overweight and
obesity. Alongside limiting energy intake, individuals are
advised to take part in regular physical activity. In the UK,
healthy adults are advised to perform at least 150min of
moderate intensity aerobic activity per week and to combine
this with muscle strengthening exercise twice a week [3].
“Exercise-induced anorexia” was a term coined in 1994 by
King and colleagues to describe the condition where appetite
is suppressed after acute exercise [4]. King et al. [4] showed
that appetite was temporarily suppressed during and after
high intensity exercise in lean healthy males. Subsequent
researchers confirmed these earlier findings [5–9]. At rest,
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feelings of hunger are mediated by gut hormones such as acy-
lated ghrelin, peptide-YY (PYY), and glucagon-like peptide-
1 (GLP-1) [10–12]. It has been hypothesised that “exercise-
induced anorexia” is mediated by altered concentrations of
these hormones. For example, acylated ghrelin (an appetite-
stimulating hormone) has been found to be suppressed
after vigorous exercise [6, 9, 13]. In contrast, circulating
concentrations of PYY and GLP-1 (satiety hormones) have
been shown to increase after exercise in healthy lean adults
[6, 9, 13]. Researchers have also examined the effects that
exercise has on energy intake after exercise. The majority
of studies indicate that individuals do not compensate for
the energy expended during exercise in the immediate hours
after exercise [14]. Therefore, these individuals are in an
energy deficit, and if maintained over time this could result
in weight loss.
Most studies on exercise and appetite regulation involve
crossover designs and relatively small sample sizes. Meta-
analyses can be useful to quantify the effects of an interven-
tion with greater precision from a pooled estimate. A stan-
dardised mean difference (SMD) is often reported. Recently,
the effects of acute exercise on appetite regulatory hormones
were examined in lean and overweight/obese individuals [15].
It was concluded that an acute bout of exercise suppresses
acylated ghrelin (SMD: 0.20) and increases PYY (SMD:
0.24), GLP-1 (SMD: 0.28), and pancreatic polypeptide (SMD:
0.50). Of the 25 studies included in this review, only two
involved overweight/obese individuals. Clearly, there are
fewer studies on overweight/obese individuals and no previ-
ous systematic review or meta-analysis has been undertaken
in this population. Such a review would capture new studies
involving overweight/obese individuals and clarify whether
they respond in a similar way to their lean counterparts. This
in turn could enhance the understanding of the role that
exercise plays in weight maintenance and control. Therefore,
we aimed to synthesise this evidence from studies investi-
gating acute exercise bouts and circulating concentrations
of acylated ghrelin, total PYY, and total GLP-1, measured in
overweight/obese participants.
2. Methods
2.1. Data Source. A systematic review of peer-reviewed stud-
ies was undertaken comparing concentrations of appetite
regulatory hormones, quantified as an area under the curve
(AUC). The review was registered with the PROSPERO
database (CRD42014006265).
The literature search was conducted by an information
specialist (JA) using commonly used research databases (Ap-
plied Social Sciences Index and Abstracts (ASSIA), Camp-
bell Collaboration, Centre for Review and Dissemination,
Database of Promoting Health Effectiveness Reviews (Do-
PHER), Cochrane Central Register of Controlled Trials
(CENTRAL), Cochrane Database of Systematic Reviews,
Cochrane Methodology Register, Database of Abstracts
of Reviews or Effects (DARE), EMBASE, NHS Economic
Evaluation Database (NHS EED), PROSPERO, PubMed,
PsycINFO MEDLINE (Ovid), Sports Discus, Scopus,
Web of Knowledge, and CINAHL). These databases were
searched in January 2014 with an update search in June
2014 and October 2016. Keyword searches were performed
for “exercise”, “physical activity”, “energy expenditure”,
“energy intake”, “appetite”, “hunger”, “food intake”,
“ghrelin”, “acylated ghrelin”, “total ghrelin”, “acyl ghrelin”,
“peptide YY”, “PYY”, “peptide YY3-36”, “PYY3-36”, “total
PYY”, “glucagon-like peptide-1”, “GLP-1”, “active GLP-
1”, “GLP-1(7-36)”, “GLP-1(9-36)”, “obese”, “overweight”,
and “appetite hormones”. Details of the search strategy
are provided in the Supplementary Material available at
http://dx.doi.org/10.1155/2016/2643625.
2.2. Inclusion Criteria. For inclusion, studies were required
to meet the following criteria: participants in the study
were overweight/obese adults, with no history of diabetes or
gastrointestinal, inflammatory, metabolic, cardiovascular, or
psychological disease; in addition, participants were required
to be nonsmokers. Study selection criteria were not limited
by the duration or observation period after exercise. To
maximise search sensitivity, there were also no limitations on
the intensity, duration, or modality of the acute exercise bout.
All studies were required to have a control condition
which was completed by the same participants who com-
pleted the exercise condition. The control condition was
required to be identical to that of the exercise condition,
minus the exercise bout.
Since the interventions were exercise bouts, investiga-
tors were not blinded. Studies were included if they were
published in peer-reviewed journals or were available in
conference proceedings, theses, or dissertations. A broad
range of sources for study inclusion were chosen to minimise
the risk of small study effects, which can occur if only
published studies are included.
2.3. Exclusion Criteria. Studies were excluded if they did not
measure acylated ghrelin, total PYY, or total GLP-1 responses
to an exercise bout in overweight/obese individuals. Studies
were also excluded if they did not include a control trial.
2.4. Study Selection. Twomembers of the research team (JAD
and KD) independently selected the studies for inclusion
in the meta-analysis and later compared notes to reach
a mutual consensus. Potential studies were identified by
examining the abstracts and full-text copies were obtained if
they met the initial criteria of evaluating appetite hormone
changes in response to an acute exercise bout. In the original
literature search conducted in January 2014, five studies met
the inclusion criteria. Twoupdate searches, conducted in June
2014 andOctober 2016, identified one further study. Together,
six studies met the inclusion criteria for the current meta-
analysis (Figure 1).
2.5. Data Synthesis. Included studies were assessed for quali-
ty and validity independently by two authors (JAD and KD),
using established criteria (Physiotherapy Evidence Data-
base [PEDro], http://www.pedro.org.au/english/downloads/
pedro%20scale/). Data on the study methods, sample size,
participant characteristics, blood analytical methods, exer-
cise intervention information, and hormone (pmol⋅L−1 h−1,
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Figure 1: Flowchart of study selection.
pg⋅mL−1 h−1, and 𝜇U⋅mL−1 h−1) and appetite AUC data were
extracted for both control and exercise conditions by one
author (JAD) into a computerised spreadsheet. Data entry
was checked by one other author (KD), and discrepancies
were discussed and checked again. If standard error of the
mean (SEM) was reported, it was converted to standard
deviations [16].
2.6. Meta-Analysis Procedures. Comprehensive meta-
analysis software (Version 2.2.064; Biostat, Englewood, NJ,
USA) was used to conduct a random effects (DerSimonian-
Laird inverse variance approach) meta-analysis of the mean
difference in acylated ghrelin, total PYY, and total GLP-1
during control and exercise trials [16]. The inputted data
included sample sizes, AUCs for the control and exercise
conditions (with their respective standard deviations), and an
imputed correlation coefficient to take into account the fact
that all studies were crossover in nature. These correlation
coefficients were estimated from prior reliability studies in
our laboratory and were as follows: acylated ghrelin 𝑟 = 0.93,
total PYY 𝑟 = 0.71, and GLP-1 𝑟 = 0.94. The software
calculated the pooled standardised difference in means to
determine the effect size [17]. All data are presented as means
(95% confidence interval).
We interpreted standardised mean difference (SMD)
values of <0.2 as trivial, 0.2–0.3 as small, 0.4–0.8 asmoderate,
and >0.8 as large [18]. A negative effect size indicates that
exercise was associated with decreased hormone concentra-
tions, whilst a positive effect size indicates that hormone
concentrations increased with exercise [19]. Heterogeneity
was explored using a 𝑄-test, 𝐼-square statistic, and the tau-
squared statistic.
2.7. Metaregression Analyses for BMI of Acylated Ghrelin AUC
between Exercise and Control Conditions. BMI was used
as a moderator in a metaregression analysis (methods-of-
moments model), to determine whether BMI could explain
the variation in effect size values seen between studies for
acylated ghrelin concentrations [17].Mean BMIs were pooled
from studies collected in the current review together with
those reported for lean individuals in a recent review by
Schubert et al. [15]. Mean BMI was included as a moderating
variable, as a negative association exists between study mean
BMI and acylated ghrelin concentrations [25]. This analysis
was only performed for acylated ghrelin as there were not
enough studies (𝑁 < 3) reporting data for total PYY or
total GLP-1 to obtain sufficiently precise and meaningful
estimations of metaregression slope.
2.8. Exploration of Small Study Effects. Small study effects
were explored with a funnel plot of standard difference
in means versus associated standard errors [26] and by
quantifying Egger’s linear regression intercept. A large and
statistically significant Egger statistic indicates the presence
of a small study effect. This analysis was only performed for
acylated ghrelin as there were not enough studies reporting
data for a precise exploration of total PYY and total GLP-1.
3. Results
3.1. Overview. Six studies involving a total of 73 participants
met the inclusion criteria for the meta-analysis. All of these
had been published (or accepted for publication) in peer-
reviewed scientific journals. The experimental trials in each
study lasted between 2 and 3 h, with exercise conducted in a
fasting condition or following a standardised breakfast.Three
studies included standardised meals before the exercise bout
[13, 21, 24] and four studies included ad libitummeals after the
exercise bout [13, 21, 22, 24]. Blood samples were collected at
regular intervals throughout all trials.
The included studies are summarised in Table 1. The
majority of studies recruited participants of the same sex.
One study recruited both males and females [21]. Two of
the studies involved more than one exercise intensity trial
[21, 22] and are reported in the analysis as “multiple trials.”
Accounting for these, the total number of trials is 10, each
including one control and one exercise condition. Six studies
(10 trials) reported acylated ghrelin AUC data, two studies
(four trials) reported total PYY AUC data, and two studies
(four trials) reported total GLP-1 AUC data. Of the 10 trials,
one used treadmill walking as the mode of exercise, two used
treadmill running, and seven used a cycle ergometer. The
mean PEDro score for the six studies was 6 ± 0, rating all
studies to have “good” methodological quality.
3.2. ParticipantDemographics andExercise InterventionChar-
acteristics. Of the 73 participants included in the meta-
analysis, 57 were men (78%) and 16 were women (22%). BMI
values of the 73 participants ranged from 27.7 to 32.7 kg⋅m−2
(mean 30.6 kg⋅m−2). Four studies used exercise which was
aerobic in nature [13, 22–24], and two compared aerobic
exercise with two variations of high intensity exercise [21,
22]. The exercise interventions lasted between 9 and 60min
(mean 34min), and exercise intensity was set between 50 and
65% VO2 peak (mean 58% VO2 peak, 𝑁 = 6) or 72.5 and
87.5% HRmax (mean 79.4% HRmax, 𝑁 = 4). Between 7 and
19 participants took part in each study (mean 12 participants)
(see Table 1 for summaries of study protocols).
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ghrelin concentrations ghrelin concentrations
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Sim et al. A
Sim et al. B
Sim et al. C
Tiryaki-Sonmez et al.
Ueda et al.
Unick et al.
Figure 2: Forest plot of effect sizes (means ± 95% confidence
intervals [CIs]) for studies evaluating the influence of acute exercise
on acylated ghrelinAUCvalues in overweight and obese individuals.
3.3. Meta-Analysis. Individual study statistics and results for
both trials including overweight/obese subjects and lean
subjects are summarised in the Supplementary Material
(Tables S1–S4).
3.4. Effect Size and Moderator Variable for Acylated Ghrelin
AUC Analysis. In overweight/obese individuals, there was
statistically significant moderate suppression in mean acy-
lated ghrelin AUC concentrations in exercise trials compared
with resting trials (pooled effect size: −0.34, 95% confidence
interval: −0.53 to −0.15; 𝑁 = 10; 𝑃 < 0.001; Figure 2).
Heterogeneity was found to be high between these studies
(𝐼2 = 87.7%; 𝑄 = 73.4, 𝑇2 = 0.084, and 𝑑𝑓 = 9). For this
reason, a random effects model was chosen to conduct the
meta-analyses [27].
Sensitivity analysis showed that the study by Gholipour
et al. [20] increased the effect size of exercise on mean acy-
lated ghrelin AUC concentrations. The removal of this study
decreased the pooled effect size to −0.23 (95% confidence
interval: −0.35 to −0.11, 𝑃 < 0.001).
When data from lean individuals were included into the
meta-analysis, with that of the previously reported over-
weight and obese individuals, the pooled standardised effect
size of exercise on acylated ghrelin AUC data was reduced
to −0.215 (95% confidence interval: −0.32 to −0.11; 𝑁 = 33;
𝑃 < 0.001).
Using BMI as a moderator in a metaregression model,
a higher mean BMI was associated with greater exercise-
induced suppression of acylated ghrelin AUC concentration.
The slope of regression for BMI was shallow, but significantly
negative (95% confidence interval: −0.07 to −0.01; 𝑃 = 0.044;
Figure 3). The standardised reduction in acylated ghrelin for
exercise versus control conditions was found to be 0.037
units more marked for every 1 kg⋅m−2 increase seen in BMI.
Including baseline acylated ghrelin concentrations and BMI
into a multiple metaregression model had little effect on the
results; the slope of regression became slightly more negative
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Figure 3: Univariable metaregression for study mean BMI versus
the acylated ghrelin AUC values in response to exercise in over-
weight and obese individuals SMD for acylated ghrelin. Data shown
is pooled from the current review and from a previous review
[15]. A negative correlation was observed which persisted even
when baseline (control) mean ghrelin concentration was added as
a covariate.
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Figure 4: Funnel plot of standard error by standard difference
in means for studies evaluating the influence of acute exercise on
acylated ghrelin AUC values in overweight/obese individuals.
so that the standardised reduction in acylated ghrelin for
exercise versus controlwas 0.040 unitsmoremarked for every
1 kg⋅m−2 increase in BMI (95% confidence interval: −0.08 to
−0.01; 𝑃 = 0.020). Sensitivity analysis showed that removal
of the study by Gholipour et al. [20] decreased the regression
slope of the BMI-ghrelin response relationship to −0.02 (95%
confidence interval: −0.05 to 0.014; 𝑃 = 0.25). However, no
methodological reason was identified for the relatively high
effect size in this particular study.
Inspection of the funnel plot (see Figure 4) and Egger’s
regression intercept revealed that there was little evidence
of small study effects (intercept = −3.647, 95% confidence
interval: −9.08 to 1.79, 𝑃 = 0.264).
3.5. Effect Size for Total PYY AUC Analysis. In overweight/
obese individuals, there was a trivial mean effect of exercise
on total PYY (pooled effect size: 0.099, 95% confidence
interval: −0.13 to 0.31; 𝑁 = 4; Figure 5), and this was not
significantly different from zero (𝑃 = 0.404). Heterogeneity
6 Journal of Obesity
concentrations concentrations
−2.00 −1.00 0.00 1.00 2.00
Standardised effect size (mean ± 95% CI)
← Decreased total PYY Increased total PYY →
Sim et al. A
Sim et al. B
Sim et al. C
Ueda et al.
Figure 5: Forest plot of effect sizes (means ± 95% confidence
intervals [CIs]) for studies evaluating the influence of acute exercise
on total PYY AUC values in overweight and obese individuals.
concentrations concentrations
−2.00 −1.00 0.00 1.00 2.00
Standardised effect size (mean ± 95% CI)
← Decreased GLP-1 Increased GLP-1 →
Martins et al. A
Martins et al. B
Martins et al. C
Unick et al.
Figure 6: Forest plot of effect sizes (means ± 95% confidence
intervals [CIs]) for studies evaluating the influence of acute exercise
on total GLP-1 AUC values in overweight and obese individuals.
was found to be low between these studies (𝐼2 = 24.17%;
𝑄 = 3.96, 𝑇2 = 0.014, and 𝑑𝑓 = 3).
3.6. Effect Size and Moderator Variable for Total GLP-1 AUC
Analysis. In overweight/obese individuals, there was a trivial
mean effect of exercise on GLP-1 (pooled effect size: −0.026,
95% confidence interval: −0.18 to 0.13;𝑁 = 4; Figure 6), and
this was not significantly different from zero (𝑃 = 0.749).
Heterogeneity was found to be high between these studies (𝐼2
= 65.7%; 𝑄 = 8.74, 𝑇2 = 0.017, and 𝑑𝑓 = 3).
4. Discussion
Understanding the responses of appetite regulatory hor-
mones to exercise and consequently the effect they may have
on energy intake and appetite could enhance the understand-
ing of the role of exercise in weight control. The purpose
of this review was to examine the concentration changes
of acylated ghrelin, total PYY, and total GLP-1 after acute
exercise in overweight/obese individuals. We found acylated
ghrelin to be moderately suppressed by acute exercise, whilst
there were trivial effects of exercise on total PYY and
total GLP-1. Ghrelin is an appetite-stimulating hormone [10]
and our results suggest that exercise in overweight/obese
individuals alters acylated ghrelin in a direction that would
be associated with decreased hunger and energy intake. We
can only speculate the effects ghrelin has on appetite and
food intake as not all studies included these measures in
their protocol. Future research should examine energy intake
in addition to appetite and appetite regulatory hormone
responses to clarify this assumption.
The results of the current review appear tomirror those of
lean individuals. In a recent review, lean individuals showed
a small reduction in acylated ghrelin after exercise, whilst
total PYY and total GLP-1 showed small increases [15].
Our findings suggest that overweight/obese individuals show
broadly similar appetite hormone responses to exercise in
lean individuals, in such a direction that could alter energy
intake and achieve weight loss if sustained over prolonged
periods of time. Again, this can only be speculated as the
studies included in both the review by Schubert et al. [15] and
the current review were acute in nature.
The present metaregression demonstrated greater exer-
cise-induced suppression of acylated ghrelin as BMI in-
creased. Although overweight/obese individuals have shown
moderate suppression of acylated ghrelin after exercise, this
suppression becomesmore prominent as BMI increases from
27.7 to 32.7 kg⋅m−2.This finding differed from that of Schubert
et al. [15], where BMI was shown to have no influence on
appetite regulatory hormones. Schubert et al. [15] included
23 studies examining responses of lean individuals and two
studies with overweight/obese individuals. The inclusion of
six, rather than two, studies with overweight/obese individu-
als in the present metaregression may explain the differences
found between the two reviews.
The current review found overweight/obese individuals
to express a moderate reduction in acylated ghrelin during
exercising conditions. Large variations in fasting and post-
prandial ghrelin concentrations between individuals make it
difficult to establish the clinical relevance that exercise has on
this hormone. In lean individuals, circulating concentrations
of acylated ghrelin in the range of 40–67 pg/mL may be
expected in fasting conditions [28], with obese individuals
expressing lower concentrations [25, 29]. We attempted to
control for differences in baseline levels of acylated ghrelin
between studies by accounting for fasting values observed in
resting trials.This had negligible influence on the relationship
between increased BMI and acylated ghrelin.
The current review found three studies that examined the
acute effects of exercise on appetite regulatory hormones in
males, two studies in females, and one study including both
males and females. Due to the limited number of studies in
this review, no conclusions can be drawn upon the effect of
exercise and sex on appetite regulatory hormones. It has been
hypothesised that exercise could influence acylated ghrelin
differently in obesemales and females. In one study, after four
days of consecutive exercise, females experienced an increase
in acylated ghrelin, whereas males showed no change [30].
This suggests that females may be prone to increasing energy
intake after exercise training. However, after acute exercise,
lean individuals have shown no sex difference in responses
of PYY3-36 or acylated ghrelin [31]. Similar relative energy
intakes were observed in males and females, suggesting that
acute exercise is equally effective for both sexes. Future
research is required to understand and compare the responses
of males and females.
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The current review has several limitations. First, only six
studies were identified as relevant following our literature
searches. We recognise that meta-analyses are not immune
from statistical power-related issues and that the pooling of
data from such a small number of studies may still provide
relatively low statistical precision (wide confidence interval
for pooled effect). For example, despite finding substantial
heterogeneity amongst studies in which ghrelin and GLP-1
were measured, precise analyses such as one for the presence
of outliers could not be performed due to the small number
of studies. We restricted our search to acute exercise trials;
further reviews should examine the effects of repeated bouts
of exercise and exercise training on appetite regulatory hor-
mones in overweight/obese individuals although at present
the literature on this aspect is very limited. The longest trial
length in the current review was 3 h; future research should
examine what happens to this population later on in the
exercising day. Despite trials only lasting 2-3 h, protocols
differed widely between studies, potentially confounding
appetite regulatory AUC estimations, specifically the timing
of exercise and meal provision within the study protocol.
AUC calculations were made over the duration of each trial,
irrespective of when exercise occurred. The inclusion of
rest periods prior to exercise into AUC calculations could
potentially underestimate the effect of exercise on hormone
responses. Additionally, studies differed by exercising par-
ticipants in both fasting and fed states. Further still, studies
varied in meal provision (standardised, ad libitum, or no
meal) after exercise. Together, these could further cofound
the study of hormonal responses to exercise. We metare-
gressed the SMD in acylated ghrelin versus study mean
BMI. Such study-level explorations of potentialmoderators of
effect size should be interpreted with caution as within-study
relationships can sometimes disagree with between-study
relationships [32].The average BMI of the participants in this
review was 30.6 kg⋅m−2 (i.e., borderline obese); therefore, we
cannot generalise the findings of this review to those who
fall higher into the obese or severely obese category. Despite
our best efforts, we cannot guarantee that we captured all the
relevant studies for this review.The fact that some researchers
studied multiple exercise conditions in their experiments
raises the issue of “double counting” in meta-analyses [33].
We acknowledge that our estimates of variance may have
been affected by this issue. Nevertheless, it was extremely
difficult to eradicate this problem because all studies were
crossover in design (rather than separate study arms) and
we already had to impute a within-subjects correlation for
the meta-analysis (because study authors tend not to report
directly the standard deviation of the mean change). Finally,
we cannot directly link the effects of exercise on appetite
regulatory hormones to weight loss and management due
to the acute nature of the studies and the lack of consis-
tency in studies including energy intake and appetite rat-
ings.
5. Conclusions
An evidence synthesis of the six studies on overweight/obese
individuals indicated that a moderate reduction in acylated
ghrelin occurs after acute exercise. Only trivial effects of
exercise were quantified for total PYY and GLP-1.
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